11/12
07:00 am
vigl
Vigil Neuroscience to Present at Upcoming Investor Conferences
Low
Report
Vigil Neuroscience to Present at Upcoming Investor Conferences
11/8
10:34 am
vigl
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target raised by analysts at Wedbush from $23.00 to $24.00. They now have an "outperform" rating on the stock.
Low
Report
Vigil Neuroscience, Inc. (NASDAQ: VIGL) had its price target raised by analysts at Wedbush from $23.00 to $24.00. They now have an "outperform" rating on the stock.
11/7
07:10 am
vigl
Vigil Neuroscience, Inc. (NASDAQ:VIGL) has caught the attention of institutional investors who hold a sizeable 41% stake [Yahoo! Finance]
Medium
Report
Vigil Neuroscience, Inc. (NASDAQ:VIGL) has caught the attention of institutional investors who hold a sizeable 41% stake [Yahoo! Finance]
11/7
07:00 am
vigl
Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update
11/5
07:00 am
vigl
Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference
Low
Report
Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference
10/9
11:58 am
vigl
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL)
Low
Report
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL)
9/27
08:36 am
vigl
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Low
Report
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
9/18
08:13 am
vigl
FDA lifts partial clinical hold on Vigil Neuroscience's Phase I VG-3927 trial [Yahoo! Finance]
Medium
Report
FDA lifts partial clinical hold on Vigil Neuroscience's Phase I VG-3927 trial [Yahoo! Finance]
9/17
07:00 am
vigl
Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927
High
Report
Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927
9/16
04:05 pm
vigl
Vigil Neuroscience to Present at Cantor Global Healthcare Conference
Low
Report
Vigil Neuroscience to Present at Cantor Global Healthcare Conference
8/29
07:00 am
vigl
Vigil Neuroscience to Present at Upcoming September Investor Conferences
Medium
Report
Vigil Neuroscience to Present at Upcoming September Investor Conferences
8/23
11:47 am
vigl
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL)
Low
Report
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL)